Skip to main content
logo
Foghorn Therapeutics Inc. (FHTX)
NASDAQ: FHTX · Real-Time Price · USD
7.06
+0.31 (4.59%)
At close: Aug 19, 2026, 4:00 PM EDT
7.20
+0.14 (1.98%)
After-hours: Aug 19, 2026, 6:00 PM EDT

Foghorn Therapeutics Revenue

Foghorn Therapeutics had revenue of $16.07M in the quarter ending June 30, 2026, with 112.68% growth. This brings the company's revenue in the last twelve months to $36.74M, up 51.98% year-over-year. In the year 2025, Foghorn Therapeutics had annual revenue of $30.91M with 36.75% growth.

Revenue (ttm)
$36.74M
Revenue Growth
+51.98%
P/S Ratio
11.41
Revenue / Employee
$346,594
Employees
106
Market Cap
419.26M

Revenue Chart

Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202530.91M8.31M36.75%
Dec 31, 202422.60M-11.55M-33.83%
Dec 31, 202334.16M14.93M77.63%
Dec 31, 202219.23M17.91M1,357.77%
Dec 31, 20211.32M889.00K206.74%
Dec 31, 2020430.00K--
Dec 31, 2019---
Dec 31, 2018---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Fennec Pharmaceuticals59.22M
vTv Therapeutics36.84M
Scribe Therapeutics36.28M
X4 Pharmaceuticals15.85M
Upstream Bio3.16M
EyePoint2.79M
Compass Therapeutics850.00K
ProKidney818.00K
Revenue Rankings

FHTX News

More News